Home » Stocks » APDN

Applied DNA Sciences, Inc. (APDN)

Stock Price: $6.66 USD -0.07 (-1.04%)
Updated Jun 21, 2021 11:31 AM EDT - Market open
Market Cap 50.38M
Revenue (ttm) 5.03M
Net Income (ttm) -13.74M
Shares Out 7.24M
EPS (ttm) -2.50
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 21
Last Price $6.66
Previous Close $6.73
Change ($) -0.07
Change (%) -1.04%
Day's Open 6.70
Day's Range 6.51 - 6.73
Day's Volume 18,219
52-Week Range 4.95 - 14.84

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

STONY BROOK, N.Y. & CHARLOTTE, N.C.--(BUSINESS WIRE)---- $APDN #AE--Applied DNA and A&E come together to bring an innovative and economical solution to brands to authenticate and validate their products.

1 week ago - Business Wire

Applied DNA Sciences Inc (NASDAQ: APDN) and its program development partner, Evvivax S.R.L., have announced results from an in vitro neutralization study of sera evaluating the company's COVID-19 vaccin...

2 weeks ago - Benzinga

STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)---- $APDN #COVIDDiagnostics--Applied DNA veterinary COVID-19 vaccine induces NAbs against B.1.1.7, P1, and B.1.526 variants; Set launch of mink challenge trial ...

2 weeks ago - Business Wire

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...

Other stocks mentioned: ACB, AMZN, ARNA, CGC, HEXO, HUGE, NEPT ...
2 weeks ago - Schaeffers Research

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--The acquisition of safeCircle's newest client reflects the service's focus on profitable niche markets and the re-opening of venues for new sales.

2 weeks ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Completes Technical Validation of SARS-CoV-2 Mutation Detection Panel; Developing Mutation that Characterizes Indian Variant.

3 weeks ago - Business Wire

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...

Other stocks mentioned: ACB, ARNA, CARA, CGC, CRBP, FLGC, GRWG ...
1 month ago - Schaeffers Research

STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), today clarifies the scope of its newly authorized asymptomatic serial screening indication f...

1 month ago - Business Wire

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -83.33% and 1.99%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced con...

1 month ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Linea™ COVID-19 Assay Kit EUA expanded to include asymptomatic serial screening as an expansion of intended use.

1 month ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, toda...

1 month ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, to...

1 month ago - Business Wire

Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)---- $APDN #COVID19Vaccine--Testing showed that neutralizing titers were detected in feline sera with a geometric mean titer for the cohort of 398.

1 month ago - Business Wire

Supply chain security provider Applied DNA Sciences, Inc. (NASDAQ:APDN) reported Wednesday it had signed a new contract with the Defense Logistics Agency's (DLA) Land and Maritime's Product Test Center ...

1 month ago - Benzinga

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #DLA--New contract with U.S. Defense Logistics Agency continues support of counterfeit mitigation program running since 2014.

1 month ago - Business Wire

Applied DNA Sciences (APDN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

1 month ago - Zacks Investment Research

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA secures amendment doubling maximal value of MSA and receives 4th purchase order from current COVID-19 Assay Kit customer.

1 month ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA provides preliminary estimated FQ2'21 revenue range of $2.5 million to $2.7 million and business update.

2 months ago - Business Wire

STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)---- $APDN #CatHealth--Preliminary results of phase I clinical trial yields high titers of SARS-CoV-2 neutralizing antibodies from all cohort members.

2 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #Cotton--Applied DNA CEO discusses relevance of DNA-based cotton traceability in textile manufacturing in interview with BBC.

2 months ago - Business Wire

Applied DNA Sciences (APDN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength d...

2 months ago - Zacks Investment Research

Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

2 months ago - Zacks Investment Research

STONY BROOK & NEW HYDE PARK, N.Y.--(BUSINESS WIRE)---- $APDN #GenomicSurveillance--Applied DNA and Northwell establish a real-time surveillance program to track and identify SARS-CoV-2 mutations and var...

2 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #ChiefLegalOfficer--Clay Shorrock rejoins the Company effective immediately to serve on the executive leadership team as Chief Legal Officer and Exec. Dir., ...

2 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the...

3 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Launches Selective Genomic Surveillance Screening Platform for SARS-CoV-2 Variant Detection and Tracking.

3 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, wi...

3 months ago - Business Wire

STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)---- $APDN #COVID19--If the veterinary vaccine candidate demonstrates effectiveness, the two companies intend to apply to USDA to enable commercial vet sales und...

3 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #DSCSA--Newly granted patent has applicability in the DNA tagging of pharmaceutical, nutraceutical and personal care excipients.

3 months ago - Business Wire

STONY BROOK, N.Y. & NEW YORK--(BUSINESS WIRE)---- $APDN #COVID19--NYC-based LIM College joins other education institutions relying on Applied DNA's safeCircle service to ensure a safe learning environment.

4 months ago - Business Wire

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -12.73% and 15.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range

4 months ago - Business Wire

STONY BROOK, N.Y. & PARSONS, Kansas--(BUSINESS WIRE)---- $APDN #COVID19--Linea(TM) COVID-19 Assay Kit utilized in genomic surveillance mode detects first instance of SARS-CoV-2 B.1.1.7 (UK) variant in K...

4 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2021 first quarter financial results after market close on Thu...

4 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--"Our veterinary vaccine program is a cost- and time-efficient path to commercializing our COVID-19 vaccine development work."

4 months ago - Business Wire

Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

TORONTO--(BUSINESS WIRE)--TruTrace Technologies, Inc. (CSE: TTT) (“TruTrace” or the “Company”), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical indust...

4 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing ...

4 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the...

5 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced tha...

5 months ago - Business Wire

Applied DNA Sciences (NASDAQ: APDN) shares are trading higher on reports the U.K. COVID strain could become the dominant strain in the U.S. The FDA last week reported the company's test is sensitive to ...

5 months ago - Benzinga

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that...

5 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the...

5 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it has ...

5 months ago - Business Wire

Applied DNA Sciences (NASDAQ: APDN) shares are trading higher after the U.S. Food and Drug Administration published communication that identifies the company's Linea COVID-19 Assay Kit as one of only tw...

5 months ago - Benzinga

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today tha...

5 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that Dr. ...

5 months ago - Business Wire

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, an...

5 months ago - Business Wire

About APDN

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fort... [Read more...]

Industry
Security & Protection Services
Founded
1983
CEO
James Hayward
Employees
59
Stock Exchange
NASDAQ
Ticker Symbol
APDN
Full Company Profile

Financial Performance

In 2020, APDN's revenue was $1.93 million, a decrease of -64.16% compared to the previous year's $5.39 million. Losses were -$13.03 million, 51.1% more than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for APDN stock is "Buy." The 12-month stock price forecast is 18.33, which is an increase of 175.23% from the latest price.

Price Target
$18.33
(175.23% upside)
Analyst Consensus: Buy